# FDA Inspection 963389 - Pinnacle, Inc - March 22, 2016

Source: https://www.keypedia.com/records/fda_inspections/pinnacle-inc/f3a31029-9ccf-4856-86b4-bbb82a038262
Source feed: FDA_Inspections

> FDA Inspection 963389 for Pinnacle, Inc on March 22, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 963389
- Company Name: Pinnacle, Inc
- Inspection Date: 2016-03-22
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1292712 - 2025-09-03](https://www.keypedia.com/records/fda_inspections/pinnacle-inc/9175b9ca-71bb-4759-b479-785ea0490af6)
- [FDA Inspection 1292712 - 2025-09-03](https://www.keypedia.com/records/fda_inspections/pinnacle-inc/77cbc66d-5e4d-4acd-bb58-b4d363e85a66)
- [FDA Inspection 1051476 - 2018-04-09](https://www.keypedia.com/records/fda_inspections/pinnacle-inc/3a593c26-237a-4278-b4a1-4832c2d70ec5)
- [FDA Inspection 848166 - 2013-09-13](https://www.keypedia.com/records/fda_inspections/pinnacle-inc/cc52fb75-8516-4ed6-bb60-5a64e416c486)

Company: https://www.keypedia.com/companies/pinnacle-inc/80166161-b89a-4eae-8471-cdab383bca8b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d